Gsk Share Discussion Threads

[spoole5] 07/12/2022 08:06

A conservative estimate!!

[patientcapital] 07/12/2022 08:05

14.29 google price

[wallywoo] 07/12/2022 08:03

Hmm 8am auction. Looking good!!

[our haven] 07/12/2022 07:51

Unfortunately you have to expect speculative litigation and set aside funds to defend against as a cost of doing business in the US. Good news that this one is dismissed though.

[tuftymatt] 07/12/2022 07:45

A positive statement so lets hope the price recovers and we push towards 1475 min before Christmas now.

[bountyhunter] 07/12/2022 07:16

Issued: 07 December 2022, London UK

Statement: Zantac (ranitidine) litigation


-- MDL Court has dismissed all cases alleging the five remaining cancers in the MDL
-- Scientific consensus is that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer

[grahamburn] 06/12/2022 21:11

Thanks. Maybe an RNS tomorrow......

[grahamburn] 06/12/2022 20:47

Can't read whole article as don't want to register, but the intro to it doesn't say GSK and HLN won the case - it says GSK and Sanofi won. However, it does say that GSK and HLN went up as a consequence of the outcome.

[bountyhunter] 06/12/2022 20:24

Short up by nearly 10% this evening in New York!

[netcurtains] 06/12/2022 20:06

The article says both GSK and HLN won a litigation case.

Is this specific case a really important thing?

[spoole5] 06/12/2022 19:36

Currently up 10% in the US

[spoole5] 06/12/2022 19:23

https://seekingalpha.com/news/3914497-glaxosmithkline-sanofi-gain-after-win-in-zantac-case

[geckotheglorious] 06/12/2022 19:23

GlaxoSmithKline, Sanofi gain after win in Zantac case

GlaxoSmithKline (NYSE:GSK) rose 4.4% and Sanofi (NASDAQ:SNY) gained 4% after winning in a Zantac product liability lawsuit. Haleon (NYSE:HLN) advanced 3.8%.
The companies were granted summary judgement by federal court in multi district litigation.

"As a result, if the plaintiff does not have this evidence, there is no genuine dispute of material fact, and the defendant is entitled to judgement as a matter of law," according to the judge's decision.
Developing story ...

[abdullla] 06/12/2022 16:57

Not allowed to rise above £14 .

[mj19] 06/12/2022 16:52

Why such a drop

[geckotheglorious] 05/12/2022 17:50

Blister1

You're welcome.
I may not be currently invested but I keep a cursory glance at news for GSK/AZN and Pfizer.

And the BB's are meant to be about ensuring most see "pertinent news"

:)

[alibizzle] 05/12/2022 16:28

In the unlikely event of Novartis bid it will be rejected as was Unilever . I hope not , but I'm sure it will

[geckotheglorious] 05/12/2022 16:10

Bilster1
last week.

GSK is a potential buyout candidate for Novartis - Intron Health”
GSK (NYSE:GSK) could be a potential buyout target for Novartis (NYSE:NVS) (OTCPK:NVSEF) as the Swiss pharma company is eyeing a large acquisition, Bloomberg reported Wednesday, citing Intron Health, an Equity Research firm based in London.

The analyst Naresh Chouhan argues that a potential combination with GSK (GSK) will enable Novartis (NVS) to re-enter the vaccine market and virology in a bid to diversify its business away from the competitive and risky oncology.

In 2015, Novartis (NVS) divested its global vaccine business (excluding influenza vaccines) to GSK (GSK), then known as GlaxoSmithKline, after a $5.25B deal.

Even with a 40% premium, the analyst projects that such a deal could be over 40% accretive after three years, assuming $2B synergies and a 6% cost of debt. A cash-based deal will lower proforma net debt to 2.4x EBITDA by 2025.
The analyst notes that the “temporary mispricing” of GSK (GSK) stock due to financial overhang from Zantac claims has paved the way for an “opportunistic” acquisition.

[tuftymatt] 05/12/2022 15:28

Nice little uptick 👍🏻

[bilster1] 05/12/2022 15:20

Where have you heard that from? How nice would that be!

[pol123] 05/12/2022 15:05

I give GSK 24 months max. GSK will be taken out IMO if price remains. Any positive news on the Daubert hearings and we will rally, not sure what level £15+ I expect

[palfrey man] 05/12/2022 15:05

Hold on, rumours of a possible bid for gsk from Novartis spreading.